BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, July 11, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
See today's BioWorld Science
Home
» Gilead Sciences patents new compounds for HIV
To read the full story,
subscribe
or
sign in
.
HIV/AIDS
Gilead Sciences patents new compounds for HIV
Nov. 6, 2023
Gilead Sciences Inc. has disclosed bridged tricyclic carbamoylpyridone compounds reported to be useful for the treatment of HIV infection.
BioWorld Science
Infection
HIV/AIDS
Patents
